AiCuris is a biopharmaceutical company focused on developing novel antiviral therapies for patients with weakened immune systems. The company advances clinical programs and a pipeline of targeted treatments aimed at infections affecting immunocompromised individuals, with programs spanning herpesviruses and BK virus among others. Headquartered in Germany, AiCuris emphasizes translating scientific discoveries into life-changing therapies for patients worldwide.
No recent news for this company.